Skip to main navigation
  Menu

ASLAN Pharmaceuticals

  • Pipeline
  • Our Team
  • Investor Relations
  • News & Publications
  • Contact
EN
english中文

Investor Relations

Investor Relations

  • Investor Home
  • Corporate Information
  • Stock Information
  • News & Events
  • Financial Information
    • SEC Filings
    • Quarterly Results
    • Analyst Coverage
  • Shareholder Services

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Alerts sign up

Required fields denoted by an asterisk ().
Alert type

SEC Filings

SEC Filings

SEC Filing Keyword Search

Filing date Form Description Filing Group View
Aug 12, 2022 6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

Current Reports
View HTML
0001193125-22-219243.pdf
0001193125-22-219243.rtf
0001193125-22-219243.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Apr 27, 2022 6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

Current Reports
View HTML
0001564590-22-015857.pdf
0001564590-22-015857.rtf
0001564590-22-015857.xls
Apr 21, 2022 SC 13G

A statement of beneficial ownership of common stock by certain persons

Other
View HTML
0001214659-22-005592.pdf
0001214659-22-005592.rtf
0001214659-22-005592.xls
Apr 01, 2022 6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

Current Reports
View HTML
0001564590-22-013244.pdf
0001564590-22-013244.rtf
0001564590-22-013244.xls
Mar 25, 2022 6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

Current Reports
View HTML
0001564590-22-011740.pdf
0001564590-22-011740.rtf
0001564590-22-011740.xls
Mar 25, 2022 20-F

Registration of securities of foreign private issuers pursuant to section 12(b) or (g)

Annual Filings
View HTML
0001564590-22-011742.pdf
0001564590-22-011742.rtf
0001564590-22-011742.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Mar 25, 2022 S-8

Securities offered to employees pursuant to employee benefit plans

Registration Statements
View HTML
0001564590-22-011746.pdf
0001564590-22-011746.rtf
0001564590-22-011746.xls
Mar 15, 2022 6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

Current Reports
View HTML
0001564590-22-010211.pdf
0001564590-22-010211.rtf
0001564590-22-010211.xls
Feb 14, 2022 SC 13G

A statement of beneficial ownership of common stock by certain persons

Other
View HTML
0000902664-22-001605.pdf
0000902664-22-001605.rtf
0000902664-22-001605.xls
Jan 21, 2022 6-K

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

Current Reports
View HTML
0001564590-22-001840.pdf
0001564590-22-001840.rtf
0001564590-22-001840.xls

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next ›
  • Last page Last »

Shareholder Tools

  • Print Page

    Print Page

  • RSS Feeds

    RSS Feeds

  • E-mail Alerts

    E-mail Alerts

Company

  • Pipeline
  • Our Team
  • Investor Relations
  • News & Publications
  • Contact
  • Terms and Conditions

Careers

For more information on employment opportunities at ASLAN, please contact us at careers@aslanpharma.com

Contact Us

Singapore Headquarters
83 Clemenceau Avenue
#12-03 UE Square
Singapore 239920
Tel: +65 6222 4235
Fax: +65 6225 2419

contact@aslanpharma.com